Antitumour metal compounds: more than theme and variations

A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs.

Matsumura, Y., & Maeda, H. (1986) · PubMed · Cited by 6,781

Cisplatin: Chemistry and Biochemistry of a Leading Anticancer Drug

(1999) · Wiley eBooks · doi:10.1002/9783906390420 · Cited by 1,296

From bench to bedside – preclinical and early clinical development of the anticancer agent indazolium trans-[tetrachlorobis(1H-indazole)ruthenate(III)] (KP1019 or FFC14A)

Hartinger, C. G., Zorbas-Seifried, S., Jakupec, M. A., Kynast, B., Zorbas, H., & Keppler, B. K. (2006) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2006.02.013 · Cited by 956

A Phase I and Pharmacological Study with Imidazolium- trans- DMSO-imidazole-tetrachlororuthenate, a Novel Ruthenium Anticancer Agent

Rademaker-Lakhai, J. M., van den Bongard, D., Pluim, D., Beijnen, J. H., & Schellens, J. H. M. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0746 · Cited by 833

Clinical development of platinum complexes in cancer therapy: an historical perspective and an update

Lebwohl, D., & Canetta, R. (1998) · European Journal of Cancer · doi:10.1016/s0959-8049(98)00224-x · Cited by 754

Update of the Preclinical Situation of Anticancer Platinum Complexes: Novel Design Strategies and Innovative Analytical Approaches

Galanski, M. S., Jakupec, M. A., & Keppler, B. K. (2005) · Current Medicinal Chemistry · doi:10.2174/0929867054637626 · Cited by 721

Metal complexes in cancer chemotherapy

Keppler, B. K. (1993) · Medical Entomology and Zoology · Cited by 688

Ruthenium metallopharmaceuticals

Clarke, M. J. (2003) · Coordination Chemistry Reviews · doi:10.1016/s0010-8545(02)00312-0 · Cited by 687

The hypoxic cell: a target for selective cancer therapy--eighteenth Bruce F. Cain Memorial Award lecture.

Brown, J. M. (1999) · PubMed · Cited by 636

Classical and Non‐Classical Ruthenium‐Based Anticancer Drugs: Towards Targeted Chemotherapy

Ang, W. H., & Dyson, P. J. (2006) · European Journal of Inorganic Chemistry · doi:10.1002/ejic.200600723 · Cited by 635

Interactions of Antitumor Metallodrugs with Serum Proteins: Advances in Characterization Using Modern Analytical Methodology

Timerbaev, A. R., Hartinger, C. G., Aleksenko, S. S., & Keppler, B. K. (2006) · Chemical Reviews · doi:10.1021/cr040704h · Cited by 614

Novel cisplatin-incorporated polymeric micelles can eradicate solid tumors in mice.

Nishiyama, N., Okazaki, S., Cabral, H., Miyamoto, M., Kato, Y., Sugiyama, Y., Nishio, K., Matsumura, Y., & Kataoka, K. (2003) · PubMed · Cited by 604

Mechanisms of Therapeutic Activity for Gallium

Bernstein, L. R. (1998) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01383-8 · Cited by 446

Copper deficiency induced by tetrathiomolybdate suppresses tumor growth and angiogenesis.

Pan, Q., Kleer, C. G., van Golen, K. L., Irani, J., Bottema, K. M., Bias, C., Carvalho, M. D., Mesri, E. A., Robins, D. M., Dick, R. D., et al. (2002) · PubMed · Cited by 434

Tumour-inhibiting platinum complexes—state of the art and future perspectives

Jakupec, M. A., Galanski, M. S., & Keppler, B. K. (2003) · Reviews of physiology, biochemistry and pharmacology · doi:10.1007/s10254-002-0001-x · Cited by 393

Transferrin Receptor Induction by Hypoxia

Tacchini, L., Bianchi, L., Bernelli-Zazzera, A., & Cairo, G. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.34.24142 · Cited by 379

Transferrin as a Metal Ion Mediator

Sun, H., Li, H., & Sadler, P. J. (1999) · Chemical Reviews · doi:10.1021/cr980430w · Cited by 377

The successful regression of large solid sarcoma 180 tumors by platinum compounds.

Rosenberg, B., & Vancamp, L. (1970) · PubMed · Cited by 376

Paullones, a Series of Cyclin-Dependent Kinase Inhibitors: Synthesis, Evaluation of CDK1/Cyclin B Inhibition, and in Vitro Antitumor Activity

Schultz, C., Link, A., Leost, M., Zaharevitz, D. W., Gussio, R., Sausville, E. A., Meijer, L., & Kunick, C. (1999) · Journal of Medicinal Chemistry · doi:10.1021/jm9900570 · Cited by 334

Gallium in cancer treatment

Collery, P., Keppler, B., Madoulet, C., & Desoize, B. (2002) · Critical Reviews in Oncology/Hematology · doi:10.1016/s1040-8428(01)00225-6 · Cited by 269

Ruthenium Half‐Sandwich Complexes Bound to Protein Kinase Pim‐1

Debreczeni, J. É., Bullock, A. N., Atilla, G. E., Williams, D. S., Bregman, H., Knapp, S., & Meggers, E. (2006) · Angewandte Chemie International Edition · doi:10.1002/anie.200503468 · Cited by 234

Recent Developments in the Field of Anticancer Platinum Complexes

Galanski, M. S. (2006) · Recent Patents on Anti-Cancer Drug Discovery · doi:10.2174/157489206777442287 · Cited by 223

A Phase I and Pharmacological Study of the Platinum Polymer AP5280 Given as an Intravenous Infusion Once Every 3 Weeks in Patients with Solid Tumors

Rademaker-Lakhai, J. M., Terret, C., Howell, S. B., Baud, C. M., de Boer, R. F., Pluim, D., Beijnen, J. H., Schellens, J. H. M., & Droz, J.-P. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0315 · Cited by 214

Transferrin binding and transferrin-mediated cellular uptake of the ruthenium coordination compound KP1019, studied by means of AAS, ESI-MS and CD spectroscopy

Pongratz, M., Schluga, P., Jakupec, M. A., Arion, V. B., Hartinger, C. G., Allmaier, G., & Keppler, B. K. (2004) · Journal of Analytical Atomic Spectrometry · doi:10.1039/b309160k · Cited by 206

The binding properties of two antitumor ruthenium(III) complexes to apotransferrin.

Kratz, F., Hartmann, M., Keppler, B., & Messori, L. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)41984-3 · Cited by 204

Preparation and biological properties of dichloro (1, 2-diaminocyclohexane) platinum (II)(DACHPt)-loaded polymeric micelles

Cabral, H., Nishiyama, N., Okazaki, S., Koyama, H., & Kataoka, K. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2004.08.022 · Cited by 201

Chemistry and Pharmacokinetics of Gallium Maltolate, a Compound With High Oral Gallium Bioavailability

Bernstein, L. R., Tanner, T., Godfrey, C., & Noll, B. (2000) · Metal-Based Drugs · doi:10.1155/mbd.2000.33 · Cited by 200

Heterocyclic complexes of ruthenium(III) induce apoptosis in colorectal carcinoma cells

Kapitza, S., Pongratz, M., Jakupec, M. A., Heffeter, P., Berger, W., Lackinger, L., Keppler, B. K., & Marian, B. (2005) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-004-0617-0 · Cited by 200

Folate-Targeted PEG as a Potential Carrier for Carboplatin Analogs. Synthesis and in Vitro Studies

Aronov, O., Horowitz, A. T., Gabizon, A., & Gibson, D. (2003) · Bioconjugate Chemistry · doi:10.1021/bc025642l · Cited by 198

A Third Mode of DNA Binding: Phosphate Clamps by a Polynuclear Platinum Complex

Komeda, S., Moulaei, T., Woods, K. K., Chikuma, M., Farrell, N. P., & Williams, L. D. (2006) · Journal of the American Chemical Society · doi:10.1021/ja062851y · Cited by 178

Tuning of Redox Potentials for the Design of Ruthenium Anticancer Drugs − an Electrochemical Study of [trans-RuCl4L(DM S O)]- and [trans-RuCl4L2]- Complexes, where L = Imidazole, 1,2,4-Triazole, Indazole

Reisner, E., Arion, V. B., Guedes da Silva, M. F. C., Lichtenecker, R., Eichinger, A., Keppler, B. K., Kukushkin, V. Y., & Pombeiro, A. J. L. (2004) · Inorganic Chemistry · doi:10.1021/ic049479c · Cited by 173

Modulation of tumor cell response to chemotherapy by the organ environment

Fidler, I. J., Wilmanns, C., Staroselsky, A., Radinsky, R., Dong, Z., & Fan, D. (1994) · Cancer and Metastasis Reviews · doi:10.1007/bf00689637 · Cited by 165

Redox-Active Antineoplastic Ruthenium Complexes with Indazole: Correlation of in Vitro Potency and Reduction Potential

Jakupec, M. A., Reisner, E., Eichinger, A., Pongratz, M., Arion, V. B., Galanski, M. S., Hartinger, C. G., & Keppler, B. K. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm0490742 · Cited by 164

Serum Proteins as Drug Carriers of Anticancer Agents: A Review

Kratz, F., & Beyer, U. (1998) · Drug Delivery · doi:10.3109/10717549809065759 · Cited by 156

Electron Transfer and Oxidative Stress as Key Factors in the Design of Drugs Selectively Active in Hypoxia.

Wardman, P. (2001) · Current Medicinal Chemistry · doi:10.2174/0929867013372959 · Cited by 150

Gallium radiopharmaceutical chemistry

Green, M. A., & Welch, M. J. (1989) · International Journal of Radiation Applications and Instrumentation Part B Nuclear Medicine and Biology · doi:10.1016/0883-2897(89)90053-6 · Cited by 149

Inhibition of endothelial cell functions and of angiogenesis by the metastasis inhibitor NAMI-A

Vacca, A., Bruno, M., Boccarelli, A., Coluccia, M., Ribatti, D., Bergamo, A., Garbisa, S., Sartor, L., & Sava, G. (2002) · British Journal of Cancer · doi:10.1038/sj.bjc.6600176 · Cited by 140

Effects of different transferrin forms on transferrin receptor expression, iron uptake, and cellular proliferation of human leukemic HL60 cells. Mechanisms responsible for the specific cytotoxicity of transferrin-gallium.

Chitambar, C. R., & Seligman, P. A. (1986) · Journal of Clinical Investigation · doi:10.1172/jci112746 · Cited by 139

Phase II studies of BBR3464, a novel tri-nuclear platinum complex, in patients with gastric or gastro-oesophageal adenocarcinoma

Jodrell, D. I., Evans, T. R. J., Steward, W. P., Cameron, D., Prendiville, J., Aschele, C., Noberasco, C., Lind, M., Carmichael, J., Dobbs, N. A., et al. (2004) · European Journal of Cancer · doi:10.1016/j.ejca.2004.04.032 · Cited by 130

Pharmacokinetics and adverse reactions of a new liposomal cisplatin (Lipoplatin): Phase I study

Stathopoulos, G. P., Boulikas, T., Vougiouka, M., Deliconstantinos, G., Rigatos, S., Darli, E., Viliotou, V., & Stathopoulos, J. (2005) · Oncology Reports · doi:10.3892/or.13.4.589 · Cited by 128

Systemic Lipoplatin infusion results in preferential tumor uptake in human studies.

Boulikas, T., Stathopoulos, G. P., Volakakis, N., & Vougiouka, M. (2005) · PubMed · Cited by 126

Synthesis, Molecular Characterization, and Biological Activity of Novel Synthetic Derivatives of Chromen-4-one in Human Cancer Cells

Barve, V., Ahmed, F., Adsule, S., Banerjee, S., Kulkarni, S., Katiyar, P., Anson, C. E., Powell, A. K., Padhyé, S., & Sarkar, F. H. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm051068y · Cited by 122

A novel charged trinuclear platinum complex effective against cisplatin-resistant tumours: hypersensitivity of p53-mutant human tumour xenografts

Pratesi, G., Perego, P., Polizzi, D., et al. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690620 · Cited by 118

Uptake of gallium-67 by human leukemic cells: demonstration of transferrin receptor-dependent and transferrin-independent mechanisms.

Chitambar, C. R., & Zivkovic, Z. (1987) · PubMed · Cited by 114

DNA-protein cross-linking by trans-[PtCl2(E-iminoether)2]. A concept for activation of the trans geometry in platinum antitumor complexes

Nováková, O., Kasparkova, J., Malina, J., Natile, G., & Brabec, V. (2003) · Nucleic Acids Research · doi:10.1093/nar/gkg863 · Cited by 105

7 The Chemistry and Biological Activity of α -(N)-Heterocyclic Carboxaldehyde Thiosemicarbazones

Agrawal, K., & Sartorelli, A. C. (1978) · Progress in medicinal chemistry · doi:10.1016/s0079-6468(08)70259-5 · Cited by 101

Synthesis and Biological Activity of Water-Soluble Maleimide Derivatives of the Anticancer Drug Carboplatin Designed as Albumin-Binding Prodrugs

Warnecke, A., Fichtner, I., Garmann, D., Jaehde, U., & Kratz, F. (2004) · Bioconjugate Chemistry · doi:10.1021/bc049829j · Cited by 101

Iron Chelators as Anti-Neoplastic Agents: Current Developments and Promise of the PIH Class of Chelators

Lovejoy, D., & Richardson, D. (2003) · Current Medicinal Chemistry · doi:10.2174/0929867033457557 · Cited by 98

Actin-dependent tumour cell adhesion after short-term exposure to the antimetastasis ruthenium complex NAMI-A

Sava, G., Frausin, F., Cocchietto, M., Vita, F., Podda, E., Spessotto, P., Furlani, A., Scarcia, V., & Zabucchi, G. (2004) · European Journal of Cancer · doi:10.1016/j.ejca.2004.01.034 · Cited by 91

p53-independent apoptosis mediated by tachpyridine, an anti-cancer iron chelator

Abeysinghe, R. D. (2001) · Carcinogenesis · doi:10.1093/carcin/22.10.1607 · Cited by 83

Correlation between metal complex formation and biological activity of nicotianamine analogues

Anderegg, G., & Ripperger, H. (1989) · Journal of the Chemical Society Chemical Communications · doi:10.1039/c39890000647 · Cited by 77

Transplatin Is Cytotoxic When Photoactivated: Enhanced Formation of DNA Cross-Links

Heringová, P., Woods, J. A., Mackay, F. S., Kašpárková, J., Sadler, P. J., & Brabec, V. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm0606692 · Cited by 74

2-Substituted paullones: CDK1/cyclin B-inhibiting property and in vitro antiproliferative activity

Kunick, C., Schultz, C., Lemcke, T., Zaharevitz, D. W., Gussio, R., Jalluri, R. K., Sausville, E. A., Leost, M., & Meijer, L. (2000) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(00)00048-2 · Cited by 70

Phase II study of oral bis (aceto) ammine dichloro (cyclohexamine) platinum (IV) (JM-216, BMS-182751) given daily x 5 in hormone refractory prostate cancer (HRPC)

Latif, T., Wood, L. S., Connell, C. F., Smith, D. C., Vaughn, D. J., Lebwohl, D., & Peereboom, D. (2004) · Investigational New Drugs · doi:10.1023/b:drug.0000047109.76766.84 · Cited by 67

Effect of gallium on DNA synthesis by human T-cell lymphoblasts.

Hedley, D. W., Tripp, E., Slowiaczek, P. R., et al. (1988) · PubMed · Cited by 66

Inhibition of N-myc expression and induction of apoptosis by iron chelation in human neuroblastoma cells.

Fan, L., Iyer, J., Zhu, S., Frick, K. K., Wada, R. K., Eskenazi, A. E., Berg, P. E., Ikegaki, N., Kennett, R. H., & Frantz, C. N. (2001) · PubMed · Cited by 64

Early results from a phase I study on orally administered tris(8-quinolinolato)gallium(III) (FFC11, KP46) in patients with solid tumors ? a CESAR study (Central European Society for Anticancer Drug Research ? EW

Hofheinz, R., Dittrich, C., Jakupec, M. A., Drescher, A., Jaehde, U., Gneist, M., von Keyserlingk, N. G., Keppler, B. K., & Hochhaus, A. (2005) · International Journal of Clinical Pharmacology and Therapeutics · doi:10.5414/cpp43590 · Cited by 64

Gallium-induced cell death in lymphoma: role of transferrin receptor cycling, involvement of Bax and the mitochondria, and effects of proteasome inhibition

Chitambar, C. R., Wereley, J. P., & Matsuyama, S. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0285 · Cited by 60

Synthesis, Characterization, and in Vitro Antitumor Activity of Osteotropic Diam(m)ineplatinum(II) Complexes Bearing a N,N-Bis(phosphonomethyl)glycine Ligand

Galanski, M. S., Slaby, S., Jakupec, M. A., & Keppler, B. K. (2003) · Journal of Medicinal Chemistry · doi:10.1021/jm0308040 · Cited by 58

Reversion of Structure-Activity Relationships of Antitumor Platinum Complexes by Acetoxime but Not Hydroxylamine Ligands

Zorbas‐Seifried, S., Jakupec, M. A., Kukushkin, N. V., Groessl, M., Hartinger, C. G., Semenova, O. P., Zorbas, H., Kukushkin, V. Y., & Keppler, B. K. (2006) · Molecular Pharmacology · doi:10.1124/mol.106.030726 · Cited by 58

A Pyrazolato‐Bridged Dinuclear Platinum( II ) Complex Induces Only Minor Distortions upon DNA‐Binding

Télétchéa, S., Komeda, S., Teuben, J., Elizondo-Riojas, M.-Á., Reedijk, J., & Kozelka, J. (2006) · Chemistry - A European Journal · doi:10.1002/chem.200500923 · Cited by 56

Gallium compounds as antineoplastic agents

Chitambar, C. R. (2004) · Current Opinion in Oncology · doi:10.1097/01.cco.0000142071.22226.d2 · Cited by 55

Preclinical activity of trans-indazolium [tetrachlorobisindazoleruthenate(III)] (NSC 666158; IndCR; KP 1019) against tumour colony-forming units and haematopoietic progenitor cells

Depenbrock, H., Schmelcher, S., Peter, R., Keppler, B. K., Weirich, G., Block, T. R., Rastetter, J., & Hanauske, A.-R. (1997) · European Journal of Cancer · doi:10.1016/s0959-8049(97)00277-3 · Cited by 54

Platinum(IV) Anticancer Complexes

Hall, M. D., Dolman, R. C., & Hambley, T. W. (2004) · CRC Press eBooks · doi:10.1201/b12414-9 · Cited by 52

Gene expression analysis of gallium-resistant and gallium-sensitive lymphoma cells reveals a role for metal-responsive transcription factor-1, metallothionein-2A, and zinc transporter-1 in modulating the antineoplastic activity of gallium nitrate

Yang, M., Kroft, S. H., & Chitambar, C. R. (2007) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0557 · Cited by 49

Chelation in Medicine

Schubert, J. (1966) · Scientific American · doi:10.1038/scientificamerican0566-40 · Cited by 47

Platinum Complexes Can Inhibit Matrix Metalloproteinase Activity: Platinum−Diethyl[(methylsulfinyl)methyl]phosphonate Complexes as Inhibitors of Matrix Metalloproteinases 2, 3, 9, and 12

Sasanelli, R., Boccarelli, A., Giordano, D., Laforgia, M., Arnesano, F., Natile, G., Cardellicchio, C., Capozzi, M. A. M., & Coluccia, M. (2007) · Journal of Medicinal Chemistry · doi:10.1021/jm061435l · Cited by 47

1 Chemical and Biological Properties of Cytotoxic α-(N)-Heterocyclic Carboxaldehyde Thiosemicarbazones

Liu, M., Lin, T., & Sartorelli, A. C. (1995) · Progress in medicinal chemistry · doi:10.1016/s0079-6468(08)70451-x · Cited by 40

The First Ruthenium-Based Paullones: Syntheses, X-ray Diffraction Structures, and Spectroscopic and Antiproliferative Properties in Vitro

Schmid, W. F., Zorbas‐Seifried, S., John, R. O., Arion, V. B., Jakupec, M. A., Roller, A., Galanski, M. S., Chiorescu, I., Zorbas, H., & Keppler, B. K. (2007) · Inorganic Chemistry · doi:10.1021/ic070098j · Cited by 39

Resistance to the Antineoplastic Agent Gallium Nitrate Results in Marked Alterations in Intracellular Iron and Gallium Trafficking: Identification of Novel Intermediates

Davies, N. P., Rahmanto, Y. S., Chitambar, C. R., & Richardson, D. R. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.099044 · Cited by 37

31 Ga Therapeutic Gallium Compounds

Bernstein, L. R. (2005) · doi:10.1002/0470864052.ch14 · Cited by 33

Gallium nitrate in multiple myeloma: Prolonged survival in a cohort of patients with advanced-stage disease

Niesvizky, R. (2003) · Seminars in Oncology · doi:10.1016/s0093-7754(03)00172-6 · Cited by 28

Synthesis, characterization and preliminary cytotoxicity assays of poly(ethylene glycol)–malonato–Pt–DACH conjugates

Furin, A., Guiotto, A., Baccichetti, F., Pasut, G., Deuschel, C., Bertani, R., & Veronese, F. M. (2003) · European Journal of Medicinal Chemistry · doi:10.1016/s0223-5234(03)00114-4 · Cited by 24

Synthesis and hydrolytic properties of polyphosphazene/(diamine)platinum/saccharide conjugates

Song, S., & Sohn, Y. S. (1998) · Journal of Controlled Release · doi:10.1016/s0168-3659(98)00046-7 · Cited by 19

Interactions of Platinum Complexes Containing Cationic, Bicyclic, Nonplanar Piperidinopiperidine Ligands with Biological Nucleophiles

Najajreh, Y., Ardeli‐Tzaraf, Y., Kašpárková, J., Heringová, P., Prilutski, D., Balter, L., Jawbry, S., Khazanov, E., Perez, J. M. T., Barenholz, Y., et al. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm060238j · Cited by 17

Hypoxia as a factor for 67Ga accumulation in tumour cells

Kinuya, S., LI, X.-F., YOKOYAMA, K., Mori, H., SHIBA, K., WATANABE, N., Shuke, N., Bunko, H., Michigishi, T., & Tonami, N. (2003) · Nuclear Medicine Communications · doi:10.1097/00006231-200401000-00007 · Cited by 13

Organometallic Anticancer Compounds

Gasser, G., Ott, I., & Metzler-Nolte, N. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm100020w · Cited by 1,624

Bioorganometallic chemistry—from teaching paradigms to medicinal applications

Hartinger, C. G., & Dyson, P. J. (2009) · Chem. Soc. Rev. · doi:10.1039/b707077m · Cited by 985

Platinum-based drugs: past, present and future

Dilruba, S., & Kalayda, G. V. (2016) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-016-2976-z · Cited by 906

Enhanced Cisplatin Chemotherapy by Iron Oxide Nanocarrier-Mediated Generation of Highly Toxic Reactive Oxygen Species

Ma, P., Xiao, H., Yu, C., Liu, J., Cheng, Z., Song, H., Zhang, X., Li, C., Wang, J., Gu, Z., et al. (2017) · Nano Letters · doi:10.1021/acs.nanolett.6b04269 · Cited by 649

Recent developments in ruthenium anticancer drugs

Levina, A., Mitra, A., & Lay, P. A. (2009) · Metallomics · doi:10.1039/b904071d · Cited by 592